Vaccine coverage reaches 75% for pediatric DTP, MMR and polio -- CDC National Immunization Survey.
Executive Summary
PEDIATRIC VACCINE COVERAGE REACHES 75% FOR DTP, MMR AND POLIO VACCINES in the U.S., based on the results of the National Immunization Survey published in the Centers for Disease Control & Prevention's Aug. 25 Morbidity and Mortality Weekly Report. The survey, conducted by CDC from April to December 1994 under the auspices of the Childhood Immunization Initiative, finds that for children ages 19-35 months, vaccination coverage was 75% for the 4:3:1 series of at least four doses of diphtheria and tetanus toxoids and pertussis vaccine, three doses of polio virus vaccine and one dose of measles-mumps-rubella vaccine.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth